Dexcom (Nasdaq:DXCM) announced that it promoted chief technology officer Jake Leach to the chief operating officer (COO) role.
Leach served as CTO since 2018, leading the company’s research, product development, product management and engineering departments. He joined the company in 2004 to lead the development of sensor electronics for its first commercial continuous glucose monitor (CGM) system.
In the 18 years Leach has been at the company, he has led teams responsible for developing multiple generations of CGMs, including the current-generation G6. Earlier this year, Leach spoke to Drug Delivery Business News about the next-generation Dexcom G7 and other offerings.
Quentin Blackford, who was Dexcom’s COO for more than four years, left in fall 2021 to become CEO of iRhythm.
Get the full story at our sister site, Drug Delivery Business News.